|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
14
|
|
pubmed:dateCreated |
2006-10-5
|
|
pubmed:abstractText |
Severe, often refractory anemia is characteristic of the myelodysplastic syndrome associated with chromosome 5q31 deletion. We investigated whether lenalidomide (CC5013) could reduce the transfusion requirement and suppress the abnormal 5q31- clone in patients with this disorder.
|
|
pubmed:commentsCorrections |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
AIM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Oct
|
|
pubmed:issn |
1533-4406
|
|
pubmed:author |
pubmed-author:BennettJohnJ,
pubmed-author:DewaldGordonG,
pubmed-author:FeldmanEricE,
pubmed-author:GiagounidisAristotleA,
pubmed-author:GreenbergPeterP,
pubmed-author:KnightRobertR,
pubmed-author:ListAlanA,
pubmed-author:Myelodysplastic Syndrome-003 Study Investigators,
pubmed-author:PatinJohnJ,
pubmed-author:PowellBayardB,
pubmed-author:RazaAzraA,
pubmed-author:ReederCraigC,
pubmed-author:SchmidtMicheleM,
pubmed-author:StoneRichardR,
pubmed-author:ThomasDeborahD,
pubmed-author:WrideKentonK,
pubmed-author:ZeldisJeromeJ
|
|
pubmed:copyrightInfo |
Copyright 2006 Massachusetts Medical Society.
|
|
pubmed:issnType |
Electronic
|
|
pubmed:day |
5
|
|
pubmed:volume |
355
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
1456-65
|
|
pubmed:dateRevised |
2007-7-17
|
|
pubmed:meshHeading |
pubmed-meshheading:17021321-Adult,
pubmed-meshheading:17021321-Aged,
pubmed-meshheading:17021321-Aged, 80 and over,
pubmed-meshheading:17021321-Bone Marrow,
pubmed-meshheading:17021321-Chromosome Aberrations,
pubmed-meshheading:17021321-Chromosome Deletion,
pubmed-meshheading:17021321-Chromosomes, Human, Pair 5,
pubmed-meshheading:17021321-Cytogenetic Analysis,
pubmed-meshheading:17021321-Erythrocyte Transfusion,
pubmed-meshheading:17021321-Female,
pubmed-meshheading:17021321-Follow-Up Studies,
pubmed-meshheading:17021321-Humans,
pubmed-meshheading:17021321-Male,
pubmed-meshheading:17021321-Middle Aged,
pubmed-meshheading:17021321-Myelodysplastic Syndromes,
pubmed-meshheading:17021321-Remission Induction,
pubmed-meshheading:17021321-Thalidomide
|
|
pubmed:year |
2006
|
|
pubmed:articleTitle |
Lenalidomide in the myelodysplastic syndrome with chromosome 5q deletion.
|
|
pubmed:affiliation |
University of South Florida College of Medicine and Malignant Hematology Division, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL 33612-9497, USA. heberten@moffitt.usf.edu
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Research Support, Non-U.S. Gov't
|
